Expression and prognostic impact of indoleamine 2,3-dioxygenase in oral squamous cell carcinomas
Authors:
- Birgit TroesterBTBirgit Troester
- Frank KlossFKFrank Kloss
- Georg SchaferGSGeorg Schafer
- Peter ObristPOPeter Obrist
- Alexander PerathonerAPAlexander Perathoner
- Johannes LaimerJLJohannes Laimer
- Gerald BrandacherGBGerald Brandacher
- Michael RasseMRMichael Rasse
- Raimund MargreiterRMRaimund Margreiter
- Albert AmbergerAAAlbert Amberger
- 1 May 2011
- journal article
- Published by Elsevier in Oral Oncology
- Vol. 47 (5) , 352-357
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Immunosuppressive Strategies that are Mediated by Tumor CellsAnnual Review of Immunology, 2007
- Immune Suppression in the Tumor MicroenvironmentJournal of Immunotherapy, 2006
- Immunosuppressive networks in the tumour environment and their therapeutic relevanceNature Reviews Cancer, 2005
- Influence of marginal and segmental mandibular resection on the survival rate in patients with squamous cell carcinoma of the inferior parts of the oral cavityJournal of Cranio-Maxillofacial Surgery, 2004
- Salvage surgery as the primary treatment for recurrent oral squamous cell carcinomaOral Oncology, 2004
- Disparities in risk of and survival from oropharyngeal squamous cell carcinomaOral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology, 2003
- Serum tryptophan decrease correlates with immune activation and impaired quality of life in colorectal cancerBritish Journal of Cancer, 2002
- T cell proliferation is blocked by indoleamine 2,3-dioxygenaseTransplantation Proceedings, 2001
- Prevention of Allogeneic Fetal Rejection by Tryptophan CatabolismScience, 1998
- Upper aerodigestive tract cancersCancer, 1995